Document is current
Any future updates will be listed below
-
Authors
Malon, Diego
Molto, Consolacion
Prasla, Shopnil
Cuthbert, Danielle
Pathak, Neha
Berner-Wygoda, Yael
Di lorio, Massimo
Li, Meredith
Savill, Jacqueline
Mittal, Abhenil
Amir, Eitan
Jhaveri, Kartik
Nadler, Michelle B.
-
Funding
Funding for this research was provided by:
Hold'em for Life Oncology Fellowships at the University of Toronto’s Temerty Faculty of Medicine.
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 4 December 2024
First Online: 25 December 2024
Declarations
:
: Dr. Diego Malon reports honoraria/speaking fee from Bristol Meyers Squibb. Dr. Consolacion Molto reports honoraria/speaking fees from AstraZeneca and Merck. Dr. Eitan Amir reports honoraria/consulting or Advisory role fees from Seagen, Gilead, AstraZeneca and Novartis. Dr. Nadler reports speaker honorarium and consulting fees from Novartis and Exact Sciences. All of them outside of the scope of this submitted work. No Conflict of Interest for Shopnil Prasla, Danielle Cuthbert, Neha Pathak, Yael Berner-Wygoda, Massimo Di lorio, Meredith Li, Jacqueline Savill, Abhenil Mittal and Kartik Jhaveri.
: This study was performed in line with the principles of the Declaration of Helsinki and The University Health Network Research Ethics Board approval was obtained (Approval Number 22-5856).
: Due to the characteristics of the study written informed consent of the participants is not required. A waiver of consent will not adversely affect the rights and welfare of the subjects. This research will not affect clinical care of the individuals.
